ShanX Medtech Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$17.6M
- Investors
-
10
ShanX Medtech General Information
Description
Developer of a diagnostic platform designed to accelerate antibiotic susceptibility testing and improve infection management. The company's platform develops rapid Antibiotic Susceptibility Testing (AST) systems that integrate real-time analysis, portability and broad-spectrum pathogen profiling, enabling healthcare providers to identify effective treatments more fast and reduce patient risk, hospital stays and antimicrobial resistance.
Contact Information
Website
www.shanxmedtech.comCorporate Office
- High Tech Campus 41
- 5656 AE Eindhoven
- Netherlands
Corporate Office
- High Tech Campus 41
- 5656 AE Eindhoven
- Netherlands
ShanX Medtech Timeline
ShanX Medtech Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Seed Round | 07-Jan-2026 | $17.6M | Completed | Generating Revenue | ||
| 4. Grant | 21-Dec-2023 | Completed | Generating Revenue | |||
| 3. Accelerator/Incubator | 09-Feb-2022 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2022 | $84.8K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 26-Nov-2020 | Completed | Generating Revenue |
ShanX Medtech Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
ShanX Medtech Patents
ShanX Medtech Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025226152-A1 | Characterization of cells | Pending | 24-Apr-2024 | ||
| CA-3222536-A1 | A microfluidic extracellular environment monitoring device | Pending | 14-Jun-2021 | ||
| EP-4104928-A1 | A microfluidic extracellular environment monitoring device | Inactive | 14-Jun-2021 | ||
| EP-4355489-A1 | A microfluidic extracellular environment monitoring device | Pending | 14-Jun-2021 | ||
| EP-4834477-A1 | A microfluidic extracellular environment monitoring device | Pending | 14-Jun-2021 | B01L3/502761 |
ShanX Medtech Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
ShanX Medtech Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Borski Fund | Venture Capital | Minority | ||
| Brabantse Ontwikkelings Maatschappij | Venture Capital | Minority | ||
| CbusineZ | Corporate Venture Capital | Minority | ||
| Invest-NL (Investment Company) | Impact Investing | Minority | ||
| Nextgen Ventures | Venture Capital | Minority |
ShanX Medtech FAQs
-
When was ShanX Medtech founded?
ShanX Medtech was founded in 2019.
-
Where is ShanX Medtech headquartered?
ShanX Medtech is headquartered in Eindhoven, Netherlands.
-
What is the size of ShanX Medtech?
ShanX Medtech has 11 total employees.
-
What industry is ShanX Medtech in?
ShanX Medtech’s primary industry is Diagnostic Equipment.
-
Is ShanX Medtech a private or public company?
ShanX Medtech is a Private company.
-
What is ShanX Medtech’s current revenue?
The current revenue for ShanX Medtech is .
-
How much funding has ShanX Medtech raised over time?
ShanX Medtech has raised $17.6M.
-
Who are ShanX Medtech’s investors?
Borski Fund, Brabantse Ontwikkelings Maatschappij, CbusineZ, Invest-NL (Investment Company), and Nextgen Ventures are 5 of 10 investors who have invested in ShanX Medtech.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
